OBJECTIVES: To identify the practices and attitudes of gynecologic oncologists regarding the end-of-life discussion. METHODS: A pilot survey was sent to 1105 members of the Society of Gynecologic Oncologists (SGO). The survey consisted of 20 questions and was sent via the website Survey Monkey. RESULTS: Response rate was 12.8%. Sixty percent of respondents were male, most ranged between 30 and 60 years of age and more than half performed 5-10 major surgeries per week. More than half of respondents (53.9%) deferred the End of Life discussion until the patient had sustained a major change in functional and/or medical status. Thirty percent initiated it at the first recurrence or progression of disease. Forty three percent of respondents characterized the discussion as an on-going process. Patients' age, social support, health insurance, and co-morbidities had no influence on the discussion, and neither did the tumor's site of origin or grade. More respondents initiated the discussion in advanced stage cancer (57%) and after salvage chemotherapy institution (54%). Forty four percent of respondents reported that "understanding and acceptance" was the initial response by patient when counseled about withdrawal of care. This increased to 86% when the issue was revisited. Confusion or reluctance to discuss the subject were initially reported to be 12% and 19%, respectively, but decreased to 2% and 3%, respectively, when withdrawal of care was subsequently addressed with the patient. CONCLUSIONS: This pilot survey sheds a light on attitudes and practices about the end-of-life discussion that deserve to be further studied.
OBJECTIVES: To identify the practices and attitudes of gynecologic oncologists regarding the end-of-life discussion. METHODS: A pilot survey was sent to 1105 members of the Society of Gynecologic Oncologists (SGO). The survey consisted of 20 questions and was sent via the website Survey Monkey. RESULTS: Response rate was 12.8%. Sixty percent of respondents were male, most ranged between 30 and 60 years of age and more than half performed 5-10 major surgeries per week. More than half of respondents (53.9%) deferred the End of Life discussion until the patient had sustained a major change in functional and/or medical status. Thirty percent initiated it at the first recurrence or progression of disease. Forty three percent of respondents characterized the discussion as an on-going process. Patients' age, social support, health insurance, and co-morbidities had no influence on the discussion, and neither did the tumor's site of origin or grade. More respondents initiated the discussion in advanced stage cancer (57%) and after salvage chemotherapy institution (54%). Forty four percent of respondents reported that "understanding and acceptance" was the initial response by patient when counseled about withdrawal of care. This increased to 86% when the issue was revisited. Confusion or reluctance to discuss the subject were initially reported to be 12% and 19%, respectively, but decreased to 2% and 3%, respectively, when withdrawal of care was subsequently addressed with the patient. CONCLUSIONS: This pilot survey sheds a light on attitudes and practices about the end-of-life discussion that deserve to be further studied.
Authors: Daniel Hong; Lauren C Das; Ellen Daily; Stacie K Levine; Olwen M Hahn; Stanley L Liauw; Daniel W Golden; Christina H Son Journal: Support Care Cancer Date: 2021-05-25 Impact factor: 3.603
Authors: Alaina J Brown; Megan J Shen; Lois M Ramondetta; Diane C Bodurka; Robert L Giuntoli; Teresa Diaz-Montes Journal: Int J Gynecol Cancer Date: 2014-10 Impact factor: 3.437
Authors: Margaret I Liang; Deanna H Wong; Christine S Walsh; Robin Farias-Eisner; Joshua G Cohen Journal: J Genet Couns Date: 2017-08-07 Impact factor: 2.537
Authors: J Brian Szender; Kassondra S Grzankowski; Kevin H Eng; Shashikant B Lele; Kunle Odunsi; Peter J Frederick Journal: Am J Clin Exp Obstet Gynecol Date: 2015
Authors: Rachel Isaksson Vogel; Sue V Petzel; Julie Cragg; Molly McClellan; Daniel Chan; Elizabeth Dickson; Julie A Jacko; François Sainfort; Melissa A Geller Journal: Gynecol Oncol Date: 2013-08-27 Impact factor: 5.482
Authors: Jenny J Ko; Mark S Ballard; Tamara Shenkier; Jessica Simon; Amanda Roze des Ordons; Gillian Fyles; Shilo Lefresne; Philippa Hawley; Charlie Chen; Michael McKenzie; Isabella Ghement; Justin J Sanders; Rachelle Bernacki; Scott Jones Journal: Palliat Med Rep Date: 2020-11-24